Role of Microglia in Neurotrauma

Neurotherapeutics

Volumn 7, Issue 4, 2010, Pages 366-377

  Loane, David J ^a   Byrnes, Kimberly R ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Inflammation; Microglia; Spinal cord injury; Traumatic brain injury

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 10; MINOCYCLINE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PROSTAGLANDIN; ROSIGLITAZONE; SUPEROXIDE;

ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; HUMAN; IMMUNITY; MICROGLIA; MOLECULAR MECHANICS; NERVE DEGENERATION; NERVOUS SYSTEM INJURY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; STROKE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICROGLIA; MODELS, BIOLOGICAL; SPINAL CORD INJURIES;

EID: 77957086962     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2010.07.002     Document Type: Article

References (198)

1. del Rio-Hortega P. Microglia. Cytology & cellular pathology of the nervous system 1932, 483-534. P.B. Hoeber, New York. W. Penfield (Ed.).
2. Spranger M., Fontana A. Activation of microglia: a dangerous interlude in immune function in the brain. Neuroscientist 1996, 2:293-299.
3. Graeber M.B., Streit W.J. Microglia: biology and pathology. Acta Neuropathol 2010, 119:89-105.
4. Weinstein J.R., Koerner I.P., Möller T. Microglia in ischemic brain injury. Future Neurol 2010, 5:227-246.
5. Yadav A., Collman R.G. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 2009, 4:430-447.
6. Jack C., Ruffini F., Bar-Or A., Antel J.P. Microglia and multiple sclerosis. J Neurosci Res 2005, 81:363-373.
7. Moisse K., Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 2006, 1762:1083-1093.
8. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., Mariani C.L. Role of microglia in the central nervous system's immune response. Neurol Res 2005, 27:685-691.
9. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
10. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
11. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 2005, 37:17-21.
12. Davalos D., Grutzendler J., Yang G., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8:752-758.
13. Liu G.J., Nagarajah R., Banati R.B., Bennett M.R. Glutamate induces directed chemotaxis of microglia. Eur J Neurosci 2009, 29:1108-1118.
14. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog Neurobiol 1999, 57:563-581.
15. Shaked I., Tchoresh D., Gersner R., et al. Protective autoimmunity: interferon-γ enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem 2005, 92:997-1009.
16. Stirling D.P., Yong V.W. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 2008, 86:1944-1958.
17. Lalancette-Hébert M., Gowing G., Simard A., Weng Y.C., Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007, 27:2596-2605.
18. Enose Y., Destache C.J., Mack A.L., et al. Proteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations. Glia 2005, 51:161-172.
19. Albright A.V., González-Scarano F. Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. J Neuroimmunol 2004, 157:27-38.
20. Milligan C.E., Levitt P., Cunningham T.J. Brain macrophages and microglia respond differently to lesions of the developing and adult visual system. J Comp Neurol 1991, 314:136-146.
21. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98.
22. Gao H.M., Hong J.S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 2008, 29:357-365.
23. Griffin W.S., Sheng J.G., Royston M.C., et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol 1998, 8:65-72.
24. Dean J.M., Wang X., Kaindl A.M., et al. Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun 2010, 24:776-783.
25. Pei Z., Pang H., Qian L., et al. MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity. Glia 2007, 55:1362-1373.
26. Pinteaux-Jones F., Sevastou I.G., Fry V.A., Heales S., Baker D., Pocock J.M. Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J Neurochem 2008, 106:442-454.
27. Fang K.M., Yang C.S., Sun S.H., Tzeng S.F. Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action. J Neurochem 2009, 111:1225-1237.
28. Zhang W., Wang T., Pei Z., et al. Aggregated α-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 2005, 19:533-542.
29. Qin L., Liu Y., Cooper C., Liu B., Wilson B., Hong J.S. Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 2002, 83:973-983.
30. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J Neurosci 2000, 20:558-567.
31. Pais T.F., Figueiredo C., Peixoto R., Braz M.H., Chatterjee S. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J Neuroinflammation 2008, 5:43.
32. + current surge. Glia 2008, 56:89-96.
33. Gao H.M., Liu B., Zhang W., Hong J.S. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J 2003, 17:1954-1956.
34. Gao H.M., Liu B., Hong J.S. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 2003, 23:6181-6187.
35. Wu D.C., Teismann P., Tieu K., et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 2003, 100:6145-6150.
36. Loane D.J., Stoica B.A., Pajoohesh-Ganji A., Byrnes K.R., Faden A.I. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem 2009, 284:15629-15639.
37. Qin L., Liu Y., Wang T., et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 2004, 279:1415-1421.
38. DeLeo F.R., Quinn M.T. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol 1996, 60:677-691.
39. Pawate S., Shen Q., Fan F., Bhat N.R. Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ. J Neurosci Res 2004, 77:540-551.
40. Chung J.Y., Choi J.H., Lee C.H., et al. Comparison of ionized calcium-binding adapter molecule 1-immunoreactive microglia in the spinal cord between young adult and aged dogs. Neurochem Res 2010, 35:620-627.
41. Godbout J.P., Chen J., Abraham J., et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 2005, 19:1329-1331.
42. Lynch A.M., Loane D.J., Minogue A.M., et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-β challenged aged hippocampus. Neurobiol Aging 2007, 28:845-855.
43. Gelinas D.S., McLaurin J. PPAR-α expression inversely correlates with inflammatory cytokines IL-1β and TNF-α in aging rats. Neurochem Res 2005, 30:1369-1375.
44. Godbout J.P., Johnson R.W. Interleukin-6 in the aging brain. J Neuroimmunol 2004, 147:141-144.
45. Murray C.A., Lynch M.A. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J Biol Chem 1998, 273:12161-12168.
46. Conde J.R., Streit W.J. Microglia in the aging brain. J Neuropathol Exp Neurol 2006, 65:199-203.
47. Baune B.T., Ponath G., Rothermundt M., Roesler A., Berger K. Association between cytokines and cerebral MRI changes in the aging brain. J Geriatr Psychiatry Neurol 2009, 22:23-34.
48. Li J., Baud O., Vartanian T., Volpe J.J., Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A 2005, 102:9936-9941.
49. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor α mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci 2008, 28:5321-5330.
50. Block M.L., Hong J.S. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 2007, 35:1127-1132.
51. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005, 201:647-657.
52. Fraser D.A., Pisalyaput K., Tenner A.J. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem 2010, 112:733-743.
53. Li L., Lu J., Tay S.S., Moochhala S.M., He B.P. The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res 2007, 1159:8-17.
54. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444.
55. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418.
56. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3:27.
57. Butovsky O., Talpalar A.E., Ben-Yaakov K., Schwartz M. Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective. Mol Cell Neurosci 2005, 29:381-393.
58. Lyons A., Griffin R.J., Costelloe C.E., Clarke R.M., Lynch M.A. IL-4 attenuates the neuroinflammation induced by amyloid-β in vivo and in vitro. J Neurochem 2007, 101:771-781.
59. Aloisi F., De Simone R., Columba-Cabezas S., Levi G. Opposite effects of interferon-γ and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J Neurosci Res 1999, 56:571-580.
60. Liu J.S., Amaral T.D., Brosnan C.F., Lee S.C. IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia. J Immunol 1998, 161:1989-1996.
61. Kiefer R., Schweitzer T., Jung S., Toyka K.V., Hartung H.P. Sequential expression of transforming growth factor-β1 by T-cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation. J Neuropathol Exp Neurol 1998, 57:385-395.
62. Elkabes S., DiCicco-Bloom E.M., Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 1996, 16:2508-2521.
63. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-640.
64. O'Keefe G.M., Nguyen V.T., Benveniste E.N. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-β, IL-4, IL-13 and IL-10. Eur J Immunol 1999, 29:1275-1285.
65. Frei K., Lins H., Schwerdel C., Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 1994, 152:2720-2728.
66. Polazzi E., Altamira L.E., Eleuteri S., et al. Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor β-2. J Neurochem 2009, 110:545-556.
67. Lai A.Y., Todd K.G. Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 2008, 56:259-270.
68. Pinteaux E., Rothwell N.J., Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 2006, 53:551-556.
69. Roy A., Liu X., Pahan K. Myelin basic protein-primed T cells induce neurotrophins in glial cells via αvβ3 [corrected] integrin [Erratum in: J Biol Chem 2008;283:3688]. J Biol Chem 2007, 282:32222-32232.
70. Bai B., Song W., Ji Y., et al. Microglia and microglia-like cell differentiated from DC inhibit CD4 T cell proliferation. PLoS One 2009, 4:e7869.
71. Neumann J., Sauerzweig S., Rönicke R., et al. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J Neurosci 2008, 28:5965-5975.
72. Bao F., Dekaban G.A., Weaver L.C. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J Neurochem 2005, 94:1361-1373.
73. Hausmann O.N. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003, 41:369-378.
74. Fitch M.T., Doller C., Combs C.K., Landreth G.E., Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 1999, 19:8182-8198.
75. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994, 6:712-724.
76. Koshinaga M., Whittemore S.R. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J Neurotrauma 1995, 12:209-222.
77. Bareyre F.M., Schwab M.E. Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci 2003, 26:555-563.
78. Popovich P.G., Guan Z., McGaughy V., Fisher L., Hickey W.F., Basso D.M. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol 2002, 61:623-633.
79. Keane R.W., Davis A.R., Dietrich W.D. Inflammatory and apoptotic signaling after spinal cord injury. J Neurotrauma 2006, 23:335-344.
80. Wang X., Arcuino G., Takano T., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004, 10:821-827.
81. Schwab J.M., Brechtel K., Nguyen T.D., Schluesener H.J. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol 2000, 111:122-130.
82. Schmitt A.B., Buss A., Breuer S., et al. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response. Acta Neuropathol 2000, 100:528-536.
83. Popovich P.G., van Rooijen N., Hickey W.F., Preidis G., McGaughy V. Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol 2003, 182:275-287.
84. Bruce-Keller A.J. Microglial-neuronal interactions in synaptic damage and recovery. J Neurosci Res 1999, 58:191-201.
85. Aggarwal B.B., Samanta A., Feldman M. TNF α. Cytokine reference: a compendium of cytokines and other mediators of host defense 2001, 413-434. Academic Press, San Diego. J.J. Oppenheim, M. Feldman (Eds.).
86. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263:C1-C16.
87. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 1997, 9:1422-1438.
88. Hayashi M., Ueyama T., Nemoto K., Tamaki T., Senba E. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 2000, 17:203-218.
89. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998, 152:74-87.
90. phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005, 25:2320-2330.
91. Zou J.Y., Crews F.T. TNF α potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFαB inhibition. Brain Res 2005, 1034:11-24.
92. Di Giovanni S., Knoblach S.M., Brandoli C., Aden S.A., Hoffman E.P., Faden A.I. Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol 2003, 53:454-468.
93. De Biase A., Knoblach S.M., Di Giovanni S., et al. Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol Genomics 2005, 22:368-381.
94. Aimone J.B., Leasure J.L., Perreau V.M., Thallmair M. Spatial and temporal gene expression profiling of the contused rat spinal cord. Exp Neurol 2004, 189:204-221.
95. Carmel J.B., Galante A., Soteropoulos P., et al. Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol Genomics 2001, 7:201-213.
96. Byrnes K.R., Garay J., Di Giovanni S., et al. Expression of two temporally distinct microglia-related gene clusters after spinal cord injury. Glia 2006, 53:420-433.
97. Zai L.J., Wrathall J.R. Cell proliferation and replacement following contusive spinal cord injury. Glia 2005, 50:247-257.
98. Carlson S.L., Parrish M.E., Springer J.E., Doty K., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998, 151:77-88.
99. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 1997, 377:443-464.
100. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., Woodruff T.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
101. Aloisi F. Immune function of microglia. Glia 2001, 36:165-179.
102. Popovich P.G., Hickey W.F. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 2001, 60:676-685.
103. Yang L., Jones N.R., Blumbergs P.C., et al. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 2005, 12:276-284.
104. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier:. I. Permeability changes after experimental spinal contusion injury. Exp Neurol 1996, 142:258-275.
105. Shechter R., London A., Varol C., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009, 6:e1000113.
106. Vaziri N.D., Lee Y.S., Lin C.Y., Lin V.W., Sindhu R.K. NAD(P)H oxidase, superoxide dismutase, catalase, glutathione peroxidase and nitric oxide synthase expression in subacute spinal cord injury. Brain Res 2004, 995:76-83.
107. Liu D., Bao F., Prough D.S., Dewitt D.S. Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: reduction by a metalloporphyrin. J Neurotrauma 2005, 22:1123-1133.
108. Bao F., Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 2002, 115:839-849.
109. Xu M., Yip G.W., Gan L.T., Ng Y.K. Distinct roles of oxidative stress and antioxidants in the nucleus dorsalis and red nucleus following spinal cord hemisection. Brain Res 2005, 1055:137-142.
110. Wu J., Yoo S., Wilcock D., et al. Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia 2010, 58:410-422.
111. Horn K.P., Busch S.A., Hawthorne A.L., van Rooijen N., Silver J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci 2008, 28:9330-9341.
112. Rolls A., Shechter R., London A., et al. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med 2008, 5:e171.
113. Slepko N., Levi G. Progressive activation of adult microglial cells in vitro. Glia 1996, 16:241-246.
114. Zhang K.H., Xiao H.S., Lu P.H., et al. Differential gene expression after complete spinal cord transection in adult rats: an analysis focused on a subchronic post-injury stage. Neuroscience 2004, 128:375-388.
115. Reichert F., Rotshenker S. Deficient activation of microglia during optic nerve degeneration. J Neuroimmunol 1996, 70:153-161.
116. Povlishock J.T., Katz D.I. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil 2005, 20:76-94.
117. McIntosh T.K., Saatman K.E., Raghupathi R., et al. The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol 1998, 24:251-267.
118. Streit W.J. The role of microglia in brain injury. Neurotoxicology 1996, 17:671-678.
119. Giordana M.T., Attanasio A., Cavalla P., Migheli A., Vigliani M.C., Schiffer D. Reactive cell proliferation and microglia following injury to the rat brain. Neuropathol Appl Neurobiol 1994, 20:163-174.
120. Haynes S.E., Hollopeter G., Yang G., et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006, 9:1512-1519.
121. Engel S., Schluesener H., Mittelbronn M., et al. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol 2000, 100:313-322.
122. Beschorner R., Nguyen T.D., Gözalan F., et al. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathol 2002, 103:541-549.
123. Gentleman S.M., Leclercq P.D., Moyes L., et al. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004, 146:97-104.
124. Csuka E., Hans V.H., Ammann E., Trentz O., Kossmann T., Morganti-Kossmann M.C. Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport 2000, 11:2587-2590.
125. Maeda J., Higuchi M., Inaji M., et al. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res 2007, 1157:100-111.
126. Raghavendra Rao V.L., Dogan A., Bowen K.K., Dempsey R.J. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol 2000, 161:102-114.
127. Raghavendra Rao V.L., Dhodda V.K., Song G., Bowen K.K., Dempsey R.J. Traumatic brain injury-induced acute gene expression changes in rat cerebral cortex identified by GeneChip analysis. J Neurosci Res 2003, 71:208-219.
128. Natale J.E., Ahmed F., Cernak I., Stoica B., Faden A.I. Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma 2003, 20:907-927.
129. Kobori N., Clifton G.L., Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res Mol Brain Res 2002, 104:148-158.
130. Israelsson C., Bengtsson H., Kylberg A., et al. Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J Neurotrauma 2008, 25:959-974.
131. Lu K.T., Wang Y.W., Yang J.T., Yang Y.L., Chen H.I. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons [Erratum in: J Neurotrauma 2009;26:469]. J Neurotrauma 2005, 22:885-895.
132. Lu K.T., Wang Y.W., Wo Y.Y., Yang Y.L. Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett 2005, 386:40-45.
133. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain. Brain Res Mol Brain Res 1995, 30:125-130.
134. Pinteaux E., Parker L.C., Rothwell N.J., Luheshi G.N. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 2002, 83:754-763.
135. Rothwell N. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 2003, 17:152-157.
136. Toulmond S., Rothwell N.J. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 1995, 671:261-266.
137. Tehranian R., Andell-Jonsson S., Beni S.M., et al. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma 2002, 19:939-951.
138. Basu A., Krady J.K., O'Malley M., Styren S.D., DeKosky S.T., Levison S.W. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci 2002, 22:6071-6082.
139. Ross S.A., Halliday M.I., Campbell G.C., Byrnes D.P., Rowlands B.J. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg 1994, 8:419-425.
140. Goodman J.C., Robertson C.S., Grossman R.G., Narayan R.K. Elevation of tumor necrosis factor in head injury. J Neuroimmunol 1990, 30:213-217.
141. Stover J.F., Schöning B., Beyer T.F., Woiciechowsky C., Unterberg A.W. Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-α in relation to brain edema and contusion following controlled cortical impact injury in rats. Neurosci Lett 2000, 288:25-28.
142. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNF α and IL-6 by brain tissue. J Cereb Blood Flow Metab 1994, 14:615-619.
143. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS. Brain Res Mol Brain Res 1996, 36:287-291.
144. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G., et al. Exacerbation of damage and altered NF-αB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 1999, 19:6248-6256.
145. Scherbel U., Raghupathi R., Nakamura M., et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A 1999, 96:8721-8726.
146. Morganti-Kossmann M.C., Hans V.H., Lenzlinger P.M., et al. TGF-β is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 1999, 16:617-628.
147. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., Joller H., Trentz O., Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood-brain barrier function. J Neuroimmunol 1999, 101:211-221.
148. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 1998, 153:143-151.
149. Kremlev S.G., Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J Neuroimmunol 2005, 162:71-80.
150. Tyor W.R., Avgeropoulos N., Ohlandt G., Hogan E.L. Treatment of spinal cord impact injury in the rat with transforming growth factor-β. J Neurol Sci 2002, 200:33-41.
151. Hamada Y., Ikata T., Katoh S., et al. Effects of exogenous transforming growth factor-β 1 on spinal cord injury in rats. Neurosci Lett 1996, 203:97-100.
152. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
153. Galbraith S. Head injuries in the elderly. Br Med J (Clin Res Ed) 1987, 294:325.
154. Pennings J.L., Bachulis B.L., Simons C.T., Slazinski T. Survival after severe brain injury in the aged. Arch Surg 1993, 128:787-793. discussion 793-784.
155. Sandhir R., Onyszchuk G., Berman N.E. Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol 2008, 213:372-380.
156. Conde J.R., Streit W.J. Effect of aging on the microglial response to peripheral nerve injury. Neurobiol Aging 2006, 27:1451-1461.
157. Popa-Wagner A., Carmichael S.T., Kokaia Z., Kessler C., Walker L.C. The response of the aged brain to stroke: too much, too soon?. Curr Neurovasc Res 2007, 4:216-227.
158. Graves A.B., White E., Koepsell T.D., et al. The association between head trauma and Alzheimer's disease. Am J Epidemiol 1990, 131:491-501.
159. Mortimer J.A., French L.R., Hutton J.T., Schuman L.M. Head injury as a risk factor for Alzheimer's disease. Neurology 1985, 35:264-267.
160. van Duijn C.M., Tanja T.A., Haaxma R., et al. Head trauma and the risk of Alzheimer's disease. Am J Epidemiol 1992, 135:775-782.
161. Ikonomovic M.D., Uryu K., Abrahamson E.E., et al. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 2004, 190:192-203.
162. Roberts G.W., Gentleman S.M., Lynch A., Graham D.I. β A4 amyloid protein deposition in brain after head trauma. Lancet 1991, 338:1422-1423.
163. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., Graham D.I. β amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994, 57:419-425.
164. Johnson V.E., Stewart W., Smith D.H. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?. Nat Rev Neurosci 2010, 11:361-370.
165. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245:417-420.
166. Cagnin A., Brooks D.J., Kennedy A.M., et al. In-vivo measurement of activated microglia in dementia [Erratum in: Lancet 2001;358:766]. Lancet 2001, 358:461-467.
167. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987, 79:195-200.
168. Ii M., Sunamoto M., Ohnishi K., Ichimori Y. β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 1996, 720:93-100.
169. Holmin S., Mathiesen T. Long-term intracerebral inflammatory response after experimental focal brain injury in rat. Neuroreport 1999, 10:1889-1891.
170. Yrjänheikki J., Keinänen R., Pellikka M., Hökfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998, 95:15769-15774.
171. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001, 21:2580-2588.
172. Kremlev S.G., Roberts R.L., Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 2004, 149:1-9.
173. Choi S.H., Lee D.Y., Chung E.S., Hong Y.B., Kim S.U., Jin B.K. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 2005, 95:1755-1765.
174. Seabrook T.J., Jiang L., Maier M., Lemere C.A. Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice. Glia 2006, 53:776-782.
175. Sanchez Mejia R.O., Ona V.O., Li M., Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001, 48:1393-1399. discussion 1399-1401.
176. Lee S.M., Yune T.Y., Kim S.J., et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 2003, 20:1017-1027.
177. Wells J.E., Hurlbert R.J., Fehlings M.G., Yong V.W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003, 126:1628-1637.
178. Stirling D.P., Khodarahmi K., Liu J., et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004, 24:2182-2190.
179. Teng Y.D., Choi H., Onario R.C., et al. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 2004, 101:3071-3076.
180. Yune T.Y., Lee J.Y., Jung G.Y., et al. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 2007, 27:7751-7761.
181. Festoff B.W., Ameenuddin S., Arnold P.M., Wong A., Santacruz K.S., Citron B.A. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 2006, 97:1314-1326.
182. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 2002, 53:409-435.
183. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001, 7:48-52.
184. 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 2006, 26:218-229.
185. Sundararajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., Landreth G.E. Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005, 130:685-696.
186. Park S.W., Yi J.H., Miranpuri G., et al. Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 2007, 320:1002-1012.
187. Collino M., Aragno M., Mastrocola R., et al. Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 2006, 530:70-80.
188. Bernardo A., Minghetti L. PPAR-γ agonists as regulators of microglial activation and brain inflammation. Curr Pharm Des 2006, 12:93-109.
189. Bethea J.R., Nagashima H., Acosta M.C., et al. Systemically administered interleukin-10 reduces tumor necrosis factor-α production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 1999, 16:851-863.
190. Morganti-Kossmann M.C., Rancan M., Stahel P.F., Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002, 8:101-105.
191. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 2001, 24:169-181.
192. Tian D.S., Xie M.J., Yu Z.Y., et al. Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Brain Res 2007, 1135:177-185.
193. Dijkstra S., Duis S., Pans I.M., et al. Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury. Exp Neurol 2006, 202:57-66.
194. Gadient R.A., Cron K.C., Otten U. Interleukin-1β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 1990, 117:335-340.
195. Bouhy D., Malgrange B., Multon S., et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 2006, 20:1239-1241.
196. Prewitt C.M., Niesman I.R., Kane C.J., Houle J.D. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 1997, 148:433-443.
197. Stoica B., Byrnes K., Faden A.I. Multifunctional drug treatment in neurotrauma. Neurotherapeutics 2009, 6:14-27.
198. Byrnes K.R., Loane D.J., Faden A.I. Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 2009, 6:94-107.